EGM
LENZ

Engineers Gate Manager’s LENZ Therapeutics LENZ Stock Holding History

Engineers Gate Manager’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,243
Closed -$295K – 2695
2026
Q1 		$295K Buy
32,243
+1,185
+4% +$16.6K ﹤0.01% 1714
2025
Q4 		$497K Buy
+31,058
New +$905K 0.01% 1365
2024
Q3 		– Sell
-14,654
Closed -$253K – 2460
2024
Q2 		$253K Buy
+14,654
New +$256K 0.01% 1547

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Engineers Gate Manager's LENZ Position: Q2 2026 in Review

Engineers Gate Manager sold out of LENZ Therapeutics (LENZ) in Q2 2026, closing a stake of 32,243 shares — an estimated $295K sold.

Engineers Gate Manager first reported a position in LENZ in Q2 2024 and held it in 3 quarters. The position peaked at $497K in Q4 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Engineers Gate Manager reported no remaining LENZ Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 32,243 LENZ Therapeutics shares in Q2 2026, an estimated $295K.
  • Engineers Gate Manager first reported a position in LENZ Therapeutics in Q2 2024 and held it in 3 quarters.
  • Engineers Gate Manager's LENZ Therapeutics position peaked at $497K in Q4 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.